A Russian company announced a successful experiment implanting 3D-printed thyroid glands into mice, and the results will be published next week, said Dmitri Fadin, development director at 3D Printing Solutions.
“We had some difficulties during the study, but in the end the thyroid gland turned out to be functional,” Mr. Fadin told RBTH. Continue reading “Russian Scientists Successfully Implant 3D-Printed Thyroid Gland”
As of this month, over 4,000 Americans are on the waiting list to receive a heart transplant. With failing hearts, these patients have no other options; heart tissue, unlike other parts of the body, is unable to heal itself once it is damaged. Fortunately, recent work by a group at Carnegie Mellon could one day lead to a world in which transplants are no longer necessary to repair damaged organs. Continue reading “Carnegie Mellon Researchers Try to Rebuild Hearts Using Biomaterials Printed with Inexpensive Printers (Video)”
Revotek, a company based in Chengdu, capital of southwest China’s Sichuan Province, released the world’s first 3D blood vessel bio-printer on Sunday.
With two nozzles working alternatively, the bio-printer can finish a 10-centimeter blood vessel within two minutes. Continue reading “Chinese Company Reveals 3D Blood Vessel Bio-Printer (Video)”
UniQuest, the main technology transfer and commercialisation company of The University of Queensland (UQ), has signed an exclusive worldwide licensing agreement with Organovo Holdings, Inc. (NYSE MKT:ONVO), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, to patent applications relating to methodology for producing kidney cells from induced pluripotent stem cells (iPSCs).
Professor Melissa Little and her team at UQ’s Institute for Molecular Bioscience developed a method of growing kidney tissue from iPSCs for potential use in drug screening, disease modelling and cell therapy. Continue reading “Organovo Patents Methodology for Producing Kidney Cells from Induced Pluripotent Stem Cells”
Sometimes it is difficult to tell the difference between news about advances in medicine and the plot for a B movie horror film. The latest developments related to bioprinting are just that kind of material and yet they are part of what is actually happening as medicine and 3D printing technology continue to work together. Just this week, CELLINK and RoosterBio have announced a partnership that allows them to pool their complementary technologies and make Cellular Bioink Kits commercially available. Continue reading “First Living Cellular Bioink Kits to Be Made Commercially Available”
3D printing technology has impacted scientific research significantly, especially when it comes to replicating the inner workings of living beings. Recently, in the case of a team of researchers based at UK’s Nottingham Trent University, the replication of organic structures is taking on a whole new dimension. Continue reading “UK Team Experiments with 4D Printing Fabrication of Artificial Muscles”
A national team of researchers has developed a first-of-its-kind, 3D-printed guide that helps regrow both the sensory and motor functions of complex nerves after injury. The groundbreaking research has the potential to help more than 200,000 people annually who experience nerve injuries or disease. Continue reading “Researchers develop 3D-printed guide that helps regenerate nerves (Video)”
The rapid development of viable inkjet technology for highly specialised applications, such as printing human cells, continues to generate significant interest. If successful, the realisation of this technology for specialised biological applications, generally known as ‘biofabrication’, has the potential to replace the long established (and often controversial) process of using animals for testing new drugs. However, there are many challenges to overcome to enable the successful production of a valve-based cell printer for the formation of human embryonic stem cell spheroid aggregates. Continue reading “Miniature Valves Play Significant Role in Viability of 3D Bio-Printing of Human Cells”
Well-financed corporations are no strangers to research, with nearly every large company even housing their own research and development departments. And seeing such businesses partner with research institutions is common, too. For instance, Organovo, the only publicly traded bioprinting company, is founded on R&D as it explores the possibilities of 3D printing human tissues. Consequently, Organovo has partnered with schools like Yale to take its research further. But what if a service or retail shop were to do the same thing? Continue reading “BioBots Announces Beta-Testing of Desktop 3D Bioprinter”
Nowadays, 3D technology is applied in many fields, from industrial production, through fashion, to the food industry. It is in medicine, however, that 3D technology shows its potential at its best.
At the beginning of 2014, history was made at University Medical Center (UMC) in Utrecht, Netherlands: a skull of a 22-year-old woman was completely replaced by a tailor-made 3D printed plastic skull. The patient was suffering from a condition that thickens the bone structure of the cranium, which causes an increasing pressure of the brain leading to vision loss, motor coordination impairment and, eventually, death. Continue reading “3D Technology Shows its Best Potential in Medicine”